药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Betaprodine
Thiotepa
The risk or severity of adverse effects can be increased when Thiotepa is combined with Baricitinib.
Betaprodine
Brequinar
The risk or severity of adverse effects can be increased when Brequinar is combined with Baricitinib.
Betaprodine
2-Methoxyethanol
The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Baricitinib.
Betaprodine
Vorinostat
The risk or severity of adverse effects can be increased when Vorinostat is combined with Baricitinib.
Betaprodine
Castanospermine
The risk or severity of adverse effects can be increased when Castanospermine is combined with Baricitinib.
Betaprodine
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Baricitinib.
4-Methoxyamphetamine
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Satralizumab
The serum concentration of Fostemsavir can be decreased when it is combined with Satralizumab.
4-Methoxyamphetamine
Abametapir
The serum concentration of Fostemsavir can be increased when it is combined with Abametapir.
4-Methoxyamphetamine
Mevastatin
The serum concentration of Mevastatin can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Voxilaprevir
The serum concentration of Voxilaprevir can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Apalutamide
The serum concentration of Fostemsavir can be decreased when it is combined with Apalutamide.
4-Methoxyamphetamine
Midostaurin
The serum concentration of Fostemsavir can be decreased when it is combined with Midostaurin.
4-Methoxyamphetamine
Ozanimod
Fostemsavir may decrease the excretion rate of Ozanimod which could result in a higher serum level.
4-Methoxyamphetamine
Rimegepant
The serum concentration of Rimegepant can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Darolutamide
The serum concentration of Darolutamide can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Cenobamate
The serum concentration of Fostemsavir can be decreased when it is combined with Cenobamate.
4-Methoxyamphetamine
Alpelisib
The serum concentration of Alpelisib can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Erdafitinib
The serum concentration of Fostemsavir can be increased when it is combined with Erdafitinib.